Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BAR 502 in Healthy Subjects
Clinical trial NCT05203367 · WITHDRAWN
Trial details
- NCT number
- NCT05203367
- Sponsor
- BAR Pharmaceuticals s.r.l.
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-25
- Primary completion
- 2023-03-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.